APA (7th ed.) Citation

A, Z., R, G., M, C., M, D. M., F, M., L, A., . . . S, G. (2025). The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives. Tumori, 111(5), 366. https://doi.org/10.1177/03008916251367339

Chicago Style (17th ed.) Citation

A, Zambelli, et al. "The Use of Bone-modifying Agents in Early Breast Cancer: AIOM Guidelines Update and Perspectives." Tumori 111, no. 5 (2025): 366. https://doi.org/10.1177/03008916251367339.

MLA (9th ed.) Citation

A, Zambelli, et al. "The Use of Bone-modifying Agents in Early Breast Cancer: AIOM Guidelines Update and Perspectives." Tumori, vol. 111, no. 5, 2025, p. 366, https://doi.org/10.1177/03008916251367339.